Is it time to move away from short-acting beta-agonists in asthma management?
Matthew J. Martin, Tim W. Harrison European Respiratory Journal 2019 53: 1802223 DOI: 10.1183/13993003.02223-2018 Frequent SABA use is associated with adverse asthma outcomes and evidence suggests replacing SABA with fast-acting LABA/ICS as reliever therapy reduces asthma exacerbation…